August 24, 2022 by Jason Wertheimer Sonoma Bio to cement its roots in Seattle with a new waterfront manufacturing and R&D site Learn More
January 26, 2022 by Jason Wertheimer Sonoma Bio Co-Founder and Chief Executive Officer Jeffrey Bluestone, Ph.D., Receives Top Scientific Honors Learn More
August 4, 2021 by Jason Wertheimer Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how Learn More
October 1, 2020 by Jason Wertheimer The time is now: Autoimmune and inflammatory diseases, meet regulatory T-cell therapy Learn More